Economic evaluation of biosimilars for reimbursement purposes – what, when, how?

Background: Limited previous research and guidelines on the design of economic evaluation for biosimilars have led to unresolved methodological questions on how to assess biosimilars. Objectives: We want to raise awareness of and explore methodological issues for the economic evaluation of biosimila...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Mark Access Health Policy
Hlavní autoři: Moorkens, Evelien, Broux, Hannah, Huys, Isabelle, Vulto, Arnold G., Simoens, Steven
Médium: Artigo
Jazyk:Inglês
Vydáno: Routledge 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7144192/
https://ncbi.nlm.nih.gov/pubmed/32284827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2020.1739509
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky